Wenqing Zhu
ORCID: 0000-0001-8229-0934Also affiliated with Fudan University, Zhongshan Hospital, The First Affiliated Hospital, Sun Yat-sen University
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 3 papers. Top paper: “Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2/3 trial”.
Jia Fan, Shaolai Zhou, Yunfan Sun, Fei Liang, Yuan Ji +22 more
Kaiyuan Fan, Alexandra P. Lewis, Lulu Wang, Wenqing Zhu, Shuang Zou +8 more
Kaiyuan Fan, Alexandra P. Lewis, Wenqing Zhu, Lulu Wang, Shuang Zou +8 more